MarketAnalysisMarketAnalysis
NYSE:ZBH

Zimmer Biomet Holdings, Inc. - NYSE:ZBH - Comprehensive analysis

Free evaluation through quantitative algorithms Zimmer Biomet Holdings, Inc. - NYSE:ZBH

Quant Rating

1

Strong Sell

2

Sell

3

Hold

4

Buy

5

Strong Buy


The overall quant rating is not an average of the factor grades listed.Instead, it gives greater weight to the metrics with the strongest predictive value.

Growth-Scoring Model Detail

Name

Fatcor
Percentage

Total Revenue Growth Over Prior Year

3.85

Market

46

Sector

53

Gross Profit Growth Over Prior Year

3.69

Market

39

Sector

51

EBITDA Growth Over Prior Year

4.99

Market

43

Sector

52

EBITA Growth Over Prior Year

5.25

Market

48

Sector

46

EBIT Growth Over Prior Year

5.19

Market

43

Sector

44

Earnings from Cont. Ops. Growth Over Prior Year

-11.69

Market

24

Sector

32

Net Income Growth Over Prior Year

-11.74

Market

25

Sector

33

Normalized Net Income Growth Over Prior Year

4.98

Market

48

Sector

39

Diluted EPS before Extra Growth Over Prior Year

-9.22

Market

27

Sector

32

A/R Growth Over Prior Year

2.66

Market

53

Sector

62

Inventory Growth Over Prior Year

-6.28

Market

18

Sector

17

PPE Net Growth Over Prior Year

-9.51

Market

7

Sector

39

Total Assets Growth Over Prior Year

-0.61

Market

31

Sector

47

Tangible Book Value Growth Over Prior Year

0

Market

0

Sector

0

Common Equity Growth Over Prior Year

-0.03

Market

34

Sector

55

Cash from Ops. Growth Over Prior Year

-5.2

Market

33

Sector

31

CAPEX Growth Over Prior Year

-26.33

Market

10

Sector

35

Dividend per Share Growth Over Prior Year

0

Market

36

Sector

48

Levered Free Cash Flow Growth Over Prior Year

-2.14

Market

36

Sector

34

Unlevered Free Cash Flow Growth Over Prior Year

-1.1

Market

38

Sector

33

Profitability-Scoring Model Detail

Name

Fatcor
Percentage

Gross Margin %

72

Market

88

Sector

74

SG&A Margin %

37.8

Market

90

Sector

48

EBITDA Margin %

33.5

Market

69

Sector

95

EBITA Margin %

28.2

Market

77

Sector

92

EBIT Margin %

20.5

Market

57

Sector

90

Earnings from Cont. Ops Margin %

11.79

Market

45

Sector

89

Net Income Margin %

11.77

Market

45

Sector

89

Net Income Avail. for Common Margin %

11.77

Market

47

Sector

89

Normalized Net Income Margin %

10.77

Market

54

Sector

90

Levered Free Cash Flow Margin %

14.49

Market

65

Sector

85

Unlevered Free Cash Flow Margin %

16.26

Market

65

Sector

86

Return on Assets %

4.59

Market

44

Sector

82

Return on Capital %

5.27

Market

32

Sector

80

Return on Equity %

7.25

Market

18

Sector

81

Return on Common Equity %

7.24

Market

18

Sector

81

Total Asset Turnover

0.36

Market

33

Sector

52

Sub-Scoring Model

Valuation
Momentum
Growth
Profitability
80
60
40
20
Valuation: 71
Momentum: 34
Growth: 34
Profitability: 53

Valuation-Scoring Model Detail

Name

Fatcor
Percentage

TEV/LTM Total Revenue

3.36

Market

46

Sector

49

TEV/LTM EBITDA

9.93

Market

22

Sector

35

P/LTM Normalized EPS

24.9

Market

35

Sector

43

P/BV

1.57

Market

17

Sector

36

TEV/LTM Unlevered FCF

18.08

Market

22

Sector

48

Momentum-Scoring Model Detail

Name

Fatcor
Percentage

1M Price Performance

-3.5

Market

21

Sector

37

3M Price Performance

7.87

Market

60

Sector

55

6M Price Performance

-10.88

Market

18

Sector

41

9M Price Performance

-6.82

Market

34

Sector

58

1Y Price Performance

-5.25

Market

35

Sector

60

Start analyzing Zimmer Biomet Holdings, Inc. - NYSE:ZBH with easy-to-understand research reports

Start analyzing Recent popular companies with easy-to-understand research reports